ALHAMBRA — History
CCN 054032 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$48M
Latest Revenue (FY2022)
+6.2%
Revenue CAGR (3yr)
34.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $43M | $46M | $48M | +4.6% | +6.2% |
| Operating Expenses | $28M | $30M | $31M | +5.1% | +5.9% |
| Operating Margin | 34.2% | 34.9% | 34.6% | -0.9% | +0.6% |
| Net Income | $15M | $16M | $17M | +3.7% | +6.9% |
| Licensed Beds | 97 | 97 | 97 | +0.0% | +0.0% |
| Total Patient Days | 30,956 | 31,809 | 32,170 | +1.1% | +1.9% |
| Medicare Day % | 10% | 10% | 11% | +9.5% | +2.9% |
| Medicaid Day % | 18% | 20% | 26% | +29.9% | +21.2% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +12.9% ($43M → $48M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.2%
This Hospital
+7.6%
State Avg
Latest Margin
34.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $51M | 34.8% |
| FY2024 (proj) | $54M | 35.0% |
| FY2025 (proj) | $56M | 35.2% |